PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 30 filers reported holding PROTEON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,017,872 | $27,423,000 | 16.02% |
| Monashee Investment Management LLC | 77,102 | $1,072,000 | 7.40% |
| Deer VII & Co. Ltd. | 315,101 | $4,383,000 | 4.15% |
| RA Capital Management | 1,506,872 | $20,961,000 | 3.01% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $13,679,000 | 2.10% |
| Omega Fund Management, LLC | 250,000 | $3,478,000 | 1.96% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,343 | $17,601,000 | 0.68% |
| Perceptive Advisors | 550,000 | $7,650,000 | 0.31% |
| TIVERTON ASSET MANAGEMENT LLC | 375,000 | $5,216,000 | 0.12% |
| Baker Brothers Advisors | 274,617 | $3,820,000 | 0.04% |